GSK plc (GSK) Stock Forecast & Price Prediction

Estimation of the future price movement of GSK plc stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target

Current $35.63

Concensus $55.00

Low $55.00

Median $55.00

High $55.00

Based on analysts projections #GSK is expected to experience a positive growth trajectory over the next year.

The current average GSK price target, as estimated by these analysts, is $55.00.

The predictions for the future GSK stock price range from a low of $55.00 to a high of $55.00, highlighting the variability of market expectations for GSK.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

GSK stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted

There are no data to display

GSK plc (GSK) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if GSK plc is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Strong Buy

Financial Scores

Updated on: 28/11/2023

Altman Z-Score: 2.0

Piotroski Score: 6.0

ESG Score

Updated on: 28/11/2023

Environmental: 58.8

Social: 66.5

Governance: 65.5

Financial Health

Updated on: 28/11/2023

DCF: Strong Buy

ROE: Buy

ROA: Neutral

Debt to equity ratio: Strong Buy

Price to earnings ratio: Strong Buy

Price to book ratio: Strong Buy

GSK Discounted Cash Flow

Updated on: 28/11/2023

Discounted Cash Flow Value

Current Price

GSK Revenues by Segment

Updated on: 28/11/2023

Sub Total

Revenue from Contract with Customer, Excluding Assessed Tax

GSK Revenues by Region

Updated on: 28/11/2023

Rest Of World

GSK Notes Due

Updated on: 28/11/2023

0001131399 NYSE 2.850% Notes due 2022
0001131399 NYSE 3.375% Notes due 2029
0001131399 NYSE 2.8750% Notes due 2022
0001131399 NYSE 3.625% Notes due 2025
0001131399 NYSE 3.875% Notes due 2028
0001131399 NYSE 2.800% Notes due 2023
0001131399 NYSE 3.375% Notes due 2023
0001131399 NYSE 3.000% Notes due 2024
0001131399 NYSE 6.375% Notes due 2038
0001131399 NYSE 4.200% Notes due 2043
0001131399 NYSE 0.534% Notes due 2023

GSK plc (GSK) Social Sentiments

Monitoring bullish and bearish sentiments towards GSK plc on Twitter and Stocktwits could help to forecast an upward or downward trend in GSK plc stock price.

No social results for GSK

Stock Forecast: Analyzing the Performance of GlaxoSmithKline (GSK) plc, a Global Pharmaceutical Giant

GlaxoSmithKline (GSK) plc is one of the top global pharmaceutical companies operating in the Drug Manufacturers - General sector. Founded in 2000 through a merger of Glaxo Wellcome and SmithKline Beecham, GSK operates in over 150 countries worldwide. GSK's diversified portfolio includes prescription drugs, vaccines, and consumer healthcare products. Some of its best-known products include Advair, Avodart, Tivicay, Relvar/Breo, Infanrix/Hib... Read more

Keys to Stock Prediction in the Drug Manufacturers - General Sector: Insight into GSK plc Performance

The Drug Manufacturers - General sector is comprised of companies that research, develop and manufacture pharmaceutical products. GSK plc (ticker: GSK) is one such company that specializes in the manufacturing of vaccines, prescription medicines and consumer healthcare products. GSK has a strong presence in the global pharmaceutical industry with a market cap of over £70 billion ($86.8 billion). The company's... Read more